Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1986-11-12
1988-12-27
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514912, A61K 3744
Patent
active
047941243
ABSTRACT:
A pharmaceutical composition containing cysteine or a pharmacologically acceptable salt thereof is an effective therapeutic agent for diabetic complications, typically diabetic cataract.
REFERENCES:
patent: 4002758 (1977-01-01), Bigou
patent: 4665082 (1987-05-01), Meister et al.
Ocular Pharmacology 4th ed.--1978 pp. 528-529--The C. V. Mosby Co.
Chem. Abst. 85:91666r (1976)--Takemoto et al.
Chem. Abst. 96:205,341r (1982)--Zhang et al.
Chem. Abst. 96 205,410r (1982)--Senju Pharm. Co. Ltd.
Yakugaku Zasshi, 89 (4), 565-578 (1969).
Azuma Mitsuyoshi
Kuriyama Hiroshi
Yamamoto Yujiro
Robinson Douglas W.
Senju Pharmaceutical Co. Ltd.
LandOfFree
Therapeutic composition for diabetic complications does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic composition for diabetic complications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic composition for diabetic complications will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-868279